Leading the Way in Respiratory Medical Devices
The name Trudell Medical International (TMI) is synonymous with the development of innovative medical devices.
We are experts in designing and manufacturing the highest quality aerosol drug delivery and lung health devices for the management of respiratory conditions.
We supply the pharmaceutical and health care industry with branded and custom respiratory medical devices and solutions to help ease the burden that respiratory challenges bring to patients and their caregivers.
Ground Breaking Innovation
Our innovation focus is to develop products that improve patient outcomes and contribute to health system savings overall.
From the industry’s first-ever compact valved holding chamber and valved holding chamber developed for children, the first breath-actuated pneumatic nebulizer to our most recently launched award winning and clinically supported OPEP device.
These and other TMI ”firsts” play a fundamental role in enhancing therapeutic treatment outcomes for patients with asthma, COPD (Chronic Obstructive Pulmonary Disease) and other respiratory conditions.
Global Brand Recognition
Our best-in-class respiratory management products have been marketed in over 110 countries worldwide, with their efficacy validated in hundreds of peer reviewed articles.
Development Grounded in Science
Aerosol science is fundamental to the product development process at TMI, so much so that our corporate headquarters is home to an industry-leading aerosol research laboratory. The fully equipped, climate controlled laboratory has stringent aerosol testing protocols validated by pharmaceutical partners and industry associations. All our devices undergo rigorous design testing and verification.
Manufactured to the Highest Quality Standards
Design, development and manufacturing are located at the corporate headquarters in London,
Canada. Six sigma quality record with robust global compliance history and Global Medical Device registrations for Class I and II devices.